In the BioHarmony Drug Report Database

"Preview" Icon

Memantine

Namenda, Axura, Ebixa (memantine) is a small molecule pharmaceutical. Memantine was first approved as Namenda on 2002-05-15. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease. It is known to target glutamate receptor ionotropic, NMDA 2C. Namenda’s patent is valid until 2029-03-24 (FDA).

 

Trade Name

 

Axura, Ebixa
 

Common Name

 

memantine
 

ChEMBL ID

 

CHEMBL807
 

Indication

 

alzheimer disease
 

Drug Class

 

Antivirals/antiparkinsonians (adamantane derivatives)

Image (chem structure or protein)

Memantine structure rendering